Head-to-Head: which drug tames facial nerve pain better?

NCT ID NCT07252453

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares carbamazepine and oxcarbazepine, two drugs used to treat trigeminal neuralgia, a condition causing severe facial pain. Researchers will enroll 122 adults aged 18-60 who have had the condition for at least two weeks. They will measure pain relief using a standard pain scale and track side effects like liver problems and dizziness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

carbamazepine and oxcarbazepine

What this could lead to

If one drug works better or has fewer side effects, it could become the preferred first-choice treatment for trigeminal neuralgia pain.

What could go wrong

This is a small, single-center study comparing two already-approved drugs. The difference may be small, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIGEMINAL NEURALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

trigeminal neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Abbassi Shaheed hospital Facio-Maxillary Department

    Karachi, Sindh, 75500, Pakistan